Sun Pharmaceutical Industries Ltd. closed 14.89% short of its 52-week high of 1,960.20 rupees, which the company achieved on ...
Laurus Labs and IPCA Labs declined 7 per cent each. Granules India, Lupin, Gland Pharma and Cipla fell 5-6 per cent. Sun Pharmaceutical Industries slipped 5 per cent while Dr Reddy's Labs was down ...
Sun Pharmaceutical Industries Ltd. closed 9.70% below its 52-week high of 1,960.20 rupees, which the company reached on ...
Sun Pharmaceuticals ... Dr Reddy’s Laboratories stock jumped 7 per cent before settling flat at ₹1,151.80. Aurobindo Pharma rose 1.51 per cent to end at ₹1,175.35 and Divi’s ...
The Nifty Pharma index closed at a gain of 2.25 percent by the end of the trading session today. IPCA Labs, Sun Pharma and Lupin emerging jumped up to 5 percent at intraday, and closed in a ...
Aurobindo Pharma followed with a 9.4 per cent rally, while Dr Reddy’s Laboratories surged 7 per cent to Rs 1,226.9. Lupin also gained nearly 7 per cent, touching Rs 2,149.2. Other notable gainers ...
Sun Pharma share price has seen a 10% decline in year-to-date (YTD) performance and an 11% drop over the past six months.
On generics, it estimated that Sun Pharma produces 20 per cent of sales within the US. This includes production at Ohm labs facility and other smaller sites. It said almost half of Taro’s ...
Donald Trump has announced reciprocal tariffs on about 60 countries, including India. He announced 27 per cent reciprocal ...
On Sunday, India-based Sun Pharmaceutical Industries Limited ... as "not of standard quality", including a batch each of Alkem Laboratories' popular antacid Pan-D, Hetero's anti-infective Cepodem ...
Structure: Navy Blue Wave 5. Position: Gray Wave 3. Next lower degree direction: Gray Wave 4. Invalidation level: 1552. A breach below 1552 would invalidate the current wave count. As long as the ...
LabVantage Pharma is the perfect solution for labs having: A preference for fast, reduced-risk deployment A desire to completely leverage GAMP 5 industry best practices An instant need for ...